We indicated that the Fc-VFD inhibits the secretion of proangiogenic factor, VEGF-A and IL-6, from cancer cells (Fig. 4), endothelial cells (Fig. 5), and macrophages [2] in the TME. This evidence concerns the gene IL6 and cancer.